Target intelligence / Profile preview

KIAA00895L pseudogene 1 (KIAA0895LP1)

Target
KIAA0895LP1
Molecular classification
Other, Pseudogene
01

Overview

KIAA00895L pseudogene 1 (KIAA0895LP1) is classified as a **unitary pseudogene**, meaning it is a genomic DNA sequence similar to a protein-coding gene but is nonfunctional due to mutations or truncations[1]. Pseudogenes do not encode proteins, and KIAA0895LP1 has no known role as a therapeutic target, receptor, enzyme, transporter, or related molecular entity. There is currently no evidence that KIAA00895L pseudogene 1 is functionally active or involved in disease. While some pseudogenes can regulate gene expression by acting as competitive endogenous RNAs or decoys for microRNAs, there are no reports describing such functions for KIAA0895LP1 specifically[2][3]. Pseudogenes like KIAA0895LP1 are studied largely as genomic elements with potential but not established regulatory or pathogenic functions. This molecule does not appear to be a direct drug target, nor is it associated with clinical pharmacology, biomarker usage, or safety concerns[1][2][3]. **Note:** - This entry is **not a therapeutic target**; it is a pseudogene, and no pharmacological or mechanistic data or disease associations are available for it. - The abbreviation appears to include a likely typographical error in the query: "KIAA00895L" (with a double zero) should be "KIAA0895L" (with a zero and an eight), as reflected in the major genetic databases[1]. - The correct abbreviation is **KIAA0895LP1**; no indications suggest otherwise[1]. - There is no additional structured or functional information available for this pseudogene in major bioinformatics resources as of this search[1][2][3][4].

Other names
KIAA0895LP1KIAA00895L pseudogene 1
02

Biological functions

OtherPseudogenes generally do not produce functional proteins, but may have regulatory functions as non-coding RNAs in some cases
03

Disease associations

OtherThere is no evidence associating KIAA00895L pseudogene 1 specifically with disease; emerging evidence suggests some pseudogenes might have regulatory roles in cancer, but there are no reports implicating this particular pseudogene

Beyond the preview

Go deeper on KIAA00895L pseudogene 1 (KIAA0895LP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on KIAA00895L pseudogene 1 (KIAA0895LP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call